FDA approves new injection to combat anthrax

EMBED </>More News Videos

Federal officials have approved a new drug for patients exposed to the deadly anthrax toxin. (WPVI)

Federal health officials have approved a new injectable drug to treat patients who have been exposed to the deadly toxin anthrax.

The Food and Drug Administration said it approved Anthim on Friday to treat inhalation anthrax, which can cause serious injury and death. The condition occurs when anthrax bacterial spores are inhaled.

Because anthrax is a potential bioterrorism weapon the U.S. government has been funding the development and production of therapies.

5 people died in 2001 after being exposed to anthrax sent in letters.

Anthim was developed by Elusys Therapeutics Inc. of Pine Brook, New Jersey, with support from the Biomedical Advanced Research and Development Authority. The government agency stockpiles vaccines, drugs and equipment for use during pandemics and other health emergencies.
Related Topics:
(Copyright ©2016 WPVI-TV. All Rights Reserved.)

Load Comments